A Study of NOX66 Plus Doxorubicin in Anthracycline-naïve, Adult Patients With Soft Tissue Sarcoma
Clinical trial NCT05100628 · TERMINATED
Trial details
- NCT number
- NCT05100628
- Sponsor
- Noxopharm Limited
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2022-02-11
- Primary completion
- 2023-05-01
- Enrollment
- 9
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.